Put Options

14 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $1.12 Million - $1.27 Million
40,500 Added 19.64%
246,700 $7.14 Million
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $5.21 Million - $6.1 Million
206,200 New
206,200 $5.77 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $1.4 Million - $1.63 Million
43,500 Added 20.08%
260,100 $8.63 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $3.42 Million - $3.95 Million
-94,600 Reduced 30.4%
216,600 $7.94 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $11.4 Million - $14.9 Million
290,000 Added 1367.92%
311,200 $12.7 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $4.33 Million - $5.65 Million
-103,600 Reduced 83.01%
21,200 $1.09 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $5.46 Million - $6.67 Million
124,800 New
124,800 $5.46 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $9.32 Million - $10.6 Million
-283,100 Reduced 70.99%
115,700 $4.53 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $5.37 Million - $6.96 Million
165,200 Added 70.72%
398,800 $14.3 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $124,092 - $150,516
3,600 Added 1.57%
233,600 $10.3 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $5.85 Million - $6.24 Million
177,500 Added 338.1%
230,000 $8.34 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $449,931 - $521,982
-14,100 Reduced 21.17%
52,500 $1.86 Million
Q4 2017

Feb 14, 2018

SELL
$33.26 - $35.29 $113,084 - $119,986
-3,400 Reduced 4.86%
66,600 $2.41 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $2.17 Million - $2.39 Million
70,000
70,000 $2.5 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.